OncoSec Medical
Business Services · New Jersey, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
365 W Passaic St Ste 400, Rochelle Park,...Phone Number
(201) 845-1000Website
www.oncosec.comRevenue
<$5 MillionStock Symbol
ONCSIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About OncoSec Medical
OncoSec Medical is a publicly traded bio-technology company that is focused on developing treatments for advanced-stage skin cancer. It is headquartered in Pennington, New Jersey.Explore more
OncoSec Medical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is OncoSec Medical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if OncoSec Medical is spiking on competitors!
Website visits: Recent activity has been detected on your website
OncoSec Medical, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on OncoSec Medical recently announced quarterly report
Check if OncoSec Medical has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when OncoSec Medical launches new products
Click to see if OncoSec Medical had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at OncoSec Medical
Funding: Get notified immidiatlly once OncoSec Medical has new funding data
Recommended Actions
Find VP level buyers at OncoSec Medical
Find more new buyers
Compare Similar Companies to OncoSec Medical
Compare insights from companies similar to OncoSec Medical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
OncoSec Medical is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
OncoSec Medical is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about OncoSec Medical.
OncoSec Medical financials insights
Gather financial insights about OncoSec Medical, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Stock Offering
$12.6M
Stock Offering
$6.9M
2016
Stock Offering
$9.1M
2017
Multiple Rounds
$16.6M
2018
Stock Offering
$23M
Corporate Investment
$15M
2019
Stock Offering
$11M
Other Financing Round
$30M
2020
Debt
$350K
2021
Stock Offering
$42M
OncoSec Medical Tech Stack
A closer look at the technologies used by OncoSec Medical
Most Recent Scoops
Facilities Relocation / Expansion
OncoSec Medical is planning to move offices in May 2025. The move will impact approximately 40 employees at the existing office located at 9810 Summers Ridge Rd, Suite # 110, San Diego, CA.
Facilities Relocation/Expansion
Left Company
Executive Move
George Chi, Chief Financial Officer, has left the organization.
Facilities Relocation / Expansion
OncoSec Medical is planning to move its offices in August 2023. The move will impact approximately 50 employees at their existing office located at 454 N 34Th Street, Seattle, WA.
Left Company
Executive Move
Promotion
Executive Move
OncoSec Medical News & Media
OncoSec Announces Closing of $1.33 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
EWING, N.J. and SAN DIEGO, May 18, 2023 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ: ONCS) (the "Company" or "OncoSec"), a clinical-stage biotechnology company developing intratumoral immunotherapies to stimulate the patient's immune system to target cancer cells and eradicate...OncoSec Announces $1.33 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
EWING, N.J. and SAN DIEGO, May 16, 2023 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ: ONCS) (the "Company" or "OncoSec"), a clinical-stage biotechnology company developing intratumoral immunotherapies to stimulate the patient's immune system to target cancer cells and eradicate...OncoSec is encouraged after FDA meeting to discuss proposed neoadjuvant melanoma clinical program
EWING, N.J. and SAN DIEGO, May 16, 2023 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ: ONCS) (the Company or OncoSec), a clinical-stage biotechnology company developing intratumoral immunotherapies to stimulate the patient's immune system to target cancer cells and eradicate...OncoSec Receives $3.49 Million to Strengthen its Balance Sheet After Selling its Net Operating Loss Tax Benefits Through The New Jersey Economic Development Authority NOL Program
EWING, N.J. and SAN DIEGO, April 27, 2023 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ: ONCS) (the Company or OncoSec), a clinical-stage biotechnology company developing intratumoral immunotherapies to stimulate the patient's immune system to target cancer cells and eradicate...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding OncoSec Medical
Sign Up For FreeTo access detailed company insights
OncoSec Medical is a publicly traded bio-technology company that is focused on developing treatments for advanced-stage skin cancer. It is headquartered in Pennington, New Jersey.... Read More
